Načítá se...
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
PURPOSE: To investigate risk factors for severe bleeding during warfarin treatment, including the influence of sex, age, comorbidity and co-medication on bleeding risk. METHODS: Patients initiating warfarin treatment between 2007 and 2011 were identified in the nationwide Swedish Prescribed Drug Reg...
Uloženo v:
| Vydáno v: | Eur J Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239828/ https://ncbi.nlm.nih.gov/pubmed/32222786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-020-02856-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|